Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab for fatigue in primary biliary cholangitis
2012-000145-12Phase 2Terminated
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Jul 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rituximab in primary biliary cholangitis (PBC), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Change in PBC-40 fatigue domain score. Started Jul 2012; status: terminated.
02
Drugs
rituximab
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2012-000145-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000145-12.